基于形态相似网络拓扑偏差映射ADHD异质性与生物型
这项病例对照研究利用多站点横断面神经发育数据集,对446名ADHD儿童和708名对照构建形态相似网络并建立拓扑指标常模,通过半监督聚类识别出三种具有不同临床-神经剖面的ADHD生物型,并在独立验证队列中重复了核心发现。
要点
- ADHD在三个拓扑指标上均表现异常枢纽组织,病例对照差异主要定位于眶额皮质的多指标协变成分。
- 研究识别出三种生物型:伴情绪失调的重度混合型、以多动/冲动为主型、以注意力不集中为主型。
- 三种生物型的神经剖面具有不同的神经化学与功能相关物,且核心发现在外部队列中重复。
核心结论
- 常模建模结合半监督聚类可从维度和分类两个层面解析ADHD异质性,识别出三种临床-神经剖面独特的生物型。
研究设计与样本
- 病例对照研究,发现队列含446名ADHD儿童(平均年龄11.5岁,标准差2.6;男339名,占76.0%)和708名对照(平均年龄11.0岁,标准差2.3;男429名,占60.6%)。
- 验证队列含554名ADHD儿童(平均年龄10.1岁,标准差2.8;男372名,占67.1%)和123名对照(平均年龄10.1岁,标准差3.0;男70名,占56.9%)。
- 构建形态相似网络并对度中心性、节点效率和参与系数三个拓扑指标建立常模,采用半监督聚类划分生物型。
- 部分样本有纵向随访认知评估,数据分析时间为2023年11月至2025年1月。
主要发现
- ADHD在全部三个拓扑指标上均表现非典型枢纽组织,病例对照差异主要定位于眶额皮质的一个协变多指标成分。
- 识别出三种生物型:伴情绪失调的重度混合型(广泛内侧前额叶-苍白球改变,n=142)、以多动/冲动为主型(前扣带回-苍白球环路改变,n=177)、以注意力不集中为主型(额上回改变,n=127)。
- 每种生物型具有不同的临床剖面和纵向轨迹,其神经剖面显示不同的神经化学与功能相关物。
- 核心发现在外部队列中重复,显示稳健的泛化性。
临床怎么用
- 常模建模衍生的拓扑偏差可作为ADHD分层标记,辅助识别具有不同临床-神经剖面的生物型。
- 三种生物型的区分有助于推进ADHD的个性化管理,但临床转化仍需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Attention-deficit/hyperactivity disorder (ADHD) is characterized by considerable clinical heterogeneity, and existing classification frameworks constrain the development of neurobiologically informed subtyping approaches. OBJECTIVE: To investigate whether normative modeling of topological properties derived from brain morphometry similarity networks can provide robust stratification markers for children with ADHD. DESIGN, SETTINGS, AND PARTICIPANTS: This case-control study leveraged multisite cross-sectional neurodevelopmental datasets with a longitudinal follow-up cognitive assessment for a subset. Morphometric similarity networks were constructed and normative models were developed for 3 topological metrics: degree centrality, nodal efficiency, and participation coefficient. Through semisupervised clustering, putative biotypes were delineated and their clinical profiles were examined. Brain profiles of these biotypes were further contextualized in terms of their neurochemical and functional correlates using large-scale databases, and model generalizability was assessed with external validation performed in an independent transdiagnostic cohort. Study data were analyzed from November 2023 to January 2025. EXPOSURES: Normative modeling of topological properties derived from brain morphometry. MAIN OUTCOMES AND MEASURES: Topological deviations in morphometric similarity networks derived from brain structural image. RESULTS: The discovery cohort comprised 446 children with ADHD (mean [SD] age, 11.5 [2.6] years; 339 male [76.0%]) and 708 controls (mean [SD] age, 11.0 [2.3] years; 429 male [60.6%]), whereas the validation cohort included 554 children with ADHD (mean [SD] age, 10.1 [2.8]; 372 male [67.1%]) and 123 controls (mean [SD] age, 10.1 [3.0]; 70 male [56.9%]). ADHD exhibited atypical hub organization across all 3 topological metrics, with significant case-control differences primarily localized to a covarying multimetric component in the orbitofrontal cortex. Three biotypes emerged: severe-combined with emotional dysregulation (widespread medial prefrontal cortex-pallidum alterations, n = 142), predominantly hyperactive/impulsive (anterior cingulate cortex-pallidum circuit alterations, n = 177), and predominantly inattentive (superior frontal gyrus alterations, n = 127), each characterized by distinct clinical profiles and longitudinal trajectories. These neural profiles of each biotype showed distinct neurochemical and functional correlates. Critically, the core findings were replicated in the validation cohort, demonstrating robust generalizability. CONCLUSIONS AND RELEVANCE: Results of this case-control study reveal that the integration of normative modeling with semisupervised clustering provided both dimensional and categorical insights into ADHD heterogeneity, identifying 3 distinct ADHD biotypes with unique clinical-neural profiles that advance the understanding of ADHD's neurobiological complexity and lay the groundwork for personalized management.
引用
- Pan N, Long Y, Qin K, et al. Mapping ADHD Heterogeneity and Biotypes by Topological Deviations in Morphometric Similarity Networks. JAMA Psychiatry. 2026. PMID: 41739459. doi:10.1001/jamapsychiatry.2026.0001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。